Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “GSK”

Belimumab in Remission of VASculitisCompleted
NCT01663623Phase 3Updated Apr 17, 2018
Sponsor: Human Genome Sciences Inc., a GSK Company
Vasculitis
United States, Australia, Belgium, Canada, Czechia +15 more
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual OnychomycosisCompleted
NCT00730405Phase 2Updated Mar 12, 2018
Sponsor: Stiefel, a GSK Company
Onychomycosis
United States, Canada, Iceland
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis SubjectsCompleted
NCT02673619Phase 2Updated Feb 9, 2018
Sponsor: Stiefel, a GSK Company
Hyperhidrosis
United States, Canada
Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque PsoriasisCompleted
NCT00716144Phase 2Updated Jan 29, 2018
Sponsor: Stiefel, a GSK Company
Psoriasis
Germany, Ireland, Netherlands, Russia, United Kingdom
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With AcneCompleted
NCT01706263Phase 4Updated Jan 8, 2018
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompleted
NCT01245140Phase 2Updated Dec 21, 2017
Sponsor: Stiefel, a GSK Company
Psoriasis
France, Germany, Netherlands, United Kingdom
A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic DiseasesCompleted
NCT01340911Phase 1Updated Oct 30, 2017
Sponsor: Sirtris, a GSK Company
Diabetes Mellitus, Type 2
United Kingdom
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type PsoriasisCompleted
NCT01154101Phase 2Updated Oct 13, 2017
Sponsor: Sirtris, a GSK Company
Psoriasis
United States
Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle FoamCompleted
NCT00842153Phase 4Updated Oct 9, 2017
Sponsor: Stiefel, a GSK Company
Psoriasis
United States
U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™Completed
NCT01706250Phase 4Updated Aug 23, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne VulgarisCompleted
NCT00757523Phase 4Updated Aug 17, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
Germany
Effect of SRT2379 on Endotoxin-Induced InflammationCompleted
NCT01262911Phase 1Updated Aug 4, 2017
Sponsor: Sirtris, a GSK Company
Sepsis
Netherlands
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy VolunteersCompleted
NCT00938275Phase 1Updated Jul 21, 2017
Sponsor: Sirtris, a GSK Company
Diabetes Mellitus, Type 2
United Kingdom
W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy VolunteersCompleted
NCT01929278Phase 1Updated Jul 18, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne VulgarisCompleted
NCT01019603Phase 1Updated Jun 23, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a CapsuleCompleted
NCT01039883Phase 1Updated Jun 22, 2017
Sponsor: Stiefel, a GSK Company
Onychomycosis
United States
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes MellitusCompleted
NCT01031108Phase 1Updated Jun 20, 2017
Sponsor: Sirtris, a GSK Company
Diabetes Mellitus, Type 2
United Kingdom
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy VolunteersCompleted
NCT01112787Phase 1Updated Jun 20, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy VolunteersCompleted
NCT01115322Phase 1Updated Jun 20, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States
A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail FungusCompleted
NCT01014962Phase 1Updated Jun 20, 2017
Sponsor: Stiefel, a GSK Company
Onychomycosis
United States
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With AcneCompleted
NCT01132443Phase 1Updated Jun 16, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompleted
NCT01984775Phase 1Updated Jun 16, 2017
Sponsor: Stiefel, a GSK Company
Psoriasis
United States, Germany
Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced InflammationCompleted
NCT01416376Phase 1Updated Jun 15, 2017
Sponsor: Sirtris, a GSK Company
Sepsis
Netherlands
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic MetastasesCompleted
NCT00920803Phase 1Updated Jun 14, 2017
Sponsor: Sirtris, a GSK Company
Neoplasms, Colorectal
United Kingdom
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.Completed
NCT01119651Phase 1Updated Jun 14, 2017
Sponsor: Stiefel, a GSK Company
Acne Vulgaris
United States

Previous page Next page